UBS AM
PRAX icon

UBS AM’s Praxis Precision Medicines PRAX Stock Holding History

UBS AM’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3M Buy
38,145
+2,857
+8% +$884K ﹤0.01% 1098
2025
Q4 		$10.4M Buy
35,288
+11,532
+49% +$2.15M ﹤0.01% 1110
2025
Q3 		$1.26M Sell
23,756
-73,189
-75% -$3.55M ﹤0.01% 1934
2025
Q2 		$4.08M Buy
96,945
+9,864
+11% +$376K ﹤0.01% 1806
2025
Q1 		$3.3M Buy
87,081
+68,466
+368% +$4.28M ﹤0.01% 1772
2024
Q4 		$1.43M Buy
18,615
+2,747
+17% +$199K ﹤0.01% 2201
2024
Q3 		$913K Sell
15,868
-6,014
-27% -$325K ﹤0.01% 2440
2024
Q2 		$905K Buy
+21,882
New +$1.03M ﹤0.01% 2426
2022
Q4 		– Sell
-1,747
Closed -$59.5K – 2708
2022
Q3 		$59.5K Buy
+1,747
New +$87K ﹤0.01% 2711

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return